See related Engerix-B inj[安在時 B 型肝炎疫苗 注射劑] information |
|
製造商 |
GlaxoSmithKline |
代理/經銷商 |
GlaxoSmithKline |
成份 |
Adsorbed purified surface antigen protein of hepatitis B virus |
適應症 |
Active immunisation against hepatitis B virus infection. |
用量 |
IM inj Adult ≥ 20 years 20-mcg dose. Neonates, infant & children up to 19 years 10-mcg dose. Primary immunization 1 dose at 0, 1, 6 months (standard schedule) or 0, 1, 2 months followed by 4th dose at 12 months after 3rd dose (accelerated schedule). Adult ≥ 20 years Rapid induction: 0, 7, 21 days followed by a 4th dose at 12 months after 1st dose. 11-15 years 20 mcg at 0, 6 months. Schedule should be used only when there is a low risk of hepatitis B infection during the vaccination course & when completion of the 2-dose vaccination course can be assured. Patients with renal insufficiency/undergoing hemodialysis 2 x 20 mcg at elected date then 1, 2, 6 months from date of 1st dose. Known or presumed HBV exposure 1 dose at 0, 1, 2-12 months. Neonates born of HBV-carrier mothers 10 mcg starting at birth at 0, 1, 2 months or 0, 1, 6 months. |
美國食品藥物管理局之懷孕等級 |
Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or embryocidal or other) and there are no controlled studies in women or studies in women and animals are not available. Drugs should be given only if the potential benefit justifies the potential risk to the foetus. |
禁忌 |
Hypersensitivity. |
注意事項 |
Delay immunization in severe acute febrile illness. Patients with renal impairment/undergoing hemodialysis, HIV infection or impaired immune system. Do not administer intravascularly or intradermally. Pregnancy & lactation. |
不良反應 |
Anorexia, irritation, headache, drowsiness, GI disturbances. Inj site reactions including pain, redness, fatigue, swelling. Depression, fever.
View ADR Monitoring Website[參閱藥物不良反應監測表格] |
本商品之市售規格 |
劑型 |
包裝 |
圖片 |
Engerix-B 注射劑 |
Engerix-B 20 mcg/1 mL x 1's |
|
|
Manufacturer: |
GlaxoSmithKline |
Distributor: |
GlaxoSmithKline |
|
|
|